The solid tumor cancer stem cell consortium (Solid TUmor CaNceR Stem cEll network, SUNRiSE network) aims to bring together scientists with a common interest for the cancer stem cell field in solid tumors. These scientists are currently or plan to develop research programs that will decipher the cancer stem cell biology.
The SUNRiSE network originated from the desire for collaboration among CSC researchers in Marseille (Pr Emmanuelle Charaffe-Jauffret and Dr Christophe Ginestier, CRCM), Montpellier (Drs Julie Pannequin and Jean-Marc Pascussi, IGF), and Nice (Dr Thierry Virolle,iBV). This project is strongly supported by the Cancéropoles Grand Sud Ouest (Cancéropole GSO) and Provence Alpes Cotes d'Azur (Cancéropole PACA).
Our specific objectives:
- To aggregate expertise and resources to build a critical mass of researchers to accelerate the rate of research discoveries in the solid tumor CSC field.
- To promote collaborations in order to coordinate efficiently requests for grant applications (National and European)
- Expand researcher’s breakthroughs to a multi-disciplinary level with a “trans-pathology” interest
- Accelerate rate and intensity of cancer stem cell research findings and their translation to clinical application (attract clinicians and pharmaceutical companies to develop anti-CSC drug-based clinical trials).
The SUNRiSE Society is now running !
By joining the SUNRiSE Society, you will be informed and participate in the SUNRISE network meetings and courses with reduced registration fees. In addition, you can, if you wish, be part of the organizing commitee, participate in working groups and receive montly the SUNRiSE Newsletter.
Membership in the SUNRiSE Society for 2018 is only 25 EUR !
SAVE THE DATES !
1st SUNRISE Training courses "Stem Cells in Solid Tumors: From Biology to Therapeutics" - June 19-20, 2018, Montpellier
This training will take place over two consecutive days and will address the rich and innovative field that represents the stem cells of solid cancers. Technical, fundamental and clinical aspects will be developed in order to offer a complete vision of the role of stem cells in cancer initiation, metastatic evolution, and tumor relapse. Opening of registrations mid-January 2018, limited places (25). For more information please visit the Cancéropole GSO web site.
Our next SUNRISE meeting will be organized in 2019 in Nice (Chateau de Valrose). Confirmed speakers are John Dick (University Health Network, Toronto, Ontario) and Julio A. Aguirre-Ghiso (Icahn School of Medicine at Mount Sinai, New York) ! We will be happy to get your suggestions and contributions for the scientific program and organization to enhance CSC networking. Please do not hesitate to contact us to share your suggestions and ideas.